Print

Cytonet GmbH & Co. KG Release: New Study Examining Therapy Option for the Most Severe Metabolic Disorders in Newborns  
4/23/2008 9:01:55 AM

WEINHEIM, Germany--(BUSINESS WIRE)--Cytonet GmbH & Co. KG, Germany’s leading cell therapy company, which is based in Weinheim, near Heidelberg, has received approval for conducting a clinical study in another field of indication for its liver cell suspension.
//-->